Delivery Order SPE2DR25D3103-SPE2DR26F9K88
- Not listed
- The Defense Logistics Agency awarded a $5,694.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10-count) on December 2, 2025, with completion due by December 3, 2025. This competitive award, which received no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,545.85 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10s. This order, issued on November 20, 2025, with completion targeted for November 21, 2025, represents a firm fixed price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded without set-aside designations, reflecting open...
- The Defense Logistics Agency awarded a delivery order valued at $1,016.96 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s) under a firm fixed-price contract with a ceiling value of $3,121.50. The order was issued on November 10, 2025, with an ultimate completion date of November 12, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively...
- The Defense Logistics Agency awarded a delivery order valued at $1,298.88 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively executed and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. This competitively awarded, firm fixed-price contract carries a ceiling value of $3,699.10 and is scheduled for completion by September 25, 2025. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $1,547.04 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10s. The contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $4,553.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10. The contract was competitively awarded without a set-aside designation and carries an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging (10s). This firm fixed price delivery order, valued at $3,745.80, represents a pediatric or small-quantity medical supply requirement for antiviral pharmaceutical support. The contract is non-set-aside and competitively awarded, with an ultimate completion date of December 2, 2025, and performance to...
- This delivery order, awarded December 5, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging. The contract carries a ceiling value of $3,648.12 with a firm fixed price structure and an ultimate completion date of December 8, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K88Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $31,839.30 to AmerisourceBergen Drug Corp for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of December 3, 2025. The contract will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 million prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has established itself as a preferred supplier for the DLA Medical Supply Chain through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contract awards demonstrate consistent capability to deliver a wide range of medications across multiple therapeutic domains, including antivirals such as Oseltamivir, supporting both Defense Health Agency and broader military healthcare requirements. The firm fixed pricing structure and competitive award process reflect AmerisourceBergen's ability to meet federal procurement standards through open competition, positioning it as a key vendor in the DLA's pharmaceutical distribution network serving military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 12/1/25 |